Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Unknown

Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study

Detection of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study.

Outcome
Outcome unknown
Phase
No phase (not a drug trial)
Status
Unknown
Study type
Interventional
Start
1 May 2024
Listed end
31 March 2025
Enrollment
250 participants
Sites
1
Primary outcomes
identification of Volatile Organic Compounds that can be related to Colorectal malignancy.
Sponsor type
Industry
Results posted
No
Last update
7 February 2024

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

Detection of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study

Detailed description public domain (ClinicalTrials.gov)

A diagnostic prospective study with no anticipated risks or constraints. Main Objective: To quantify differences in exhaled breath VOCs of patients with colorectal or pancreatic cancers compared with cohorts without cancer.